CD19-targeted CAR-T Therapy

· Chongqing Precision Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CD19-targeted CAR-T Therapy, covering 2017-03-22 to 2024-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis [Phase 1]